ELXR Stock Overview
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Elixxer Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.15 |
52 Week High | CA$2.00 |
52 Week Low | CA$0.50 |
Beta | 1.56 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -23.33% |
3 Year Change | -86.47% |
5 Year Change | -87.90% |
Change since IPO | -94.00% |
Recent News & Updates
Recent updates
Shareholder Returns
ELXR | CA Capital Markets | CA Market | |
---|---|---|---|
7D | 0% | 1.5% | 1.2% |
1Y | -23.3% | 26.2% | 6.1% |
Return vs Industry: ELXR underperformed the Canadian Capital Markets industry which returned 9.9% over the past year.
Return vs Market: ELXR underperformed the Canadian Market which returned -0.8% over the past year.
Price Volatility
ELXR volatility | |
---|---|
ELXR Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.2% |
Market Average Movement | 9.1% |
10% most volatile stocks in CA Market | 18.1% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: ELXR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ELXR's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | n/a | Ferras Zalt | www.elixxer.com |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd.
Elixxer Ltd. Fundamentals Summary
ELXR fundamental statistics | |
---|---|
Market cap | CA$13.05m |
Earnings (TTM) | -CA$8.80m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.5x
P/E RatioIs ELXR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ELXR income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$8.80m |
Earnings | -CA$8.80m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.78 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 159.9% |
How did ELXR perform over the long term?
See historical performance and comparison